Interpace Diagnostics Group, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Interpace Diagnostics Group, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Interpace Diagnostics Group, Inc..